RESKUE Trial for Patients with Krabbe Disease

With new beginnings comes new hope. As we enter 2021, screening will begin for the our Phase 1/2 RESKUE trial – the first in-human gene therapy clinical trial for patients with Krabbe Disease. Learn more about the RESKUE trial here – https://clinicaltrials.gov/ct2/show/NCT04693598?term=NCT04693598

0/5 (0 Reviews)